CANF Net Income Growth
Can-Fite Biopharma Ltd American Depositary Shares, each representing two (2) Ordinary Shares · Net Income Growth
CANF Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-8.57%period ending
CANF TTM Net Income YoY % (-34.44% → -8.57%)
Year-over-year change
High-resolution chart · PNG
CANF net income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Net Income Growth |
|---|---|
| -8.5692% | |
| -16.2% | |
| -24.7208% | |
| -23.0236% | |
| -19.3732% | |
| -18.0814% | |
| -5.4604% | |
| 13.7265% | |
| 22.033% | |
| 30.875% | |
| 28.0916% | |
| 24.0523% | |
| 24.4466% | |
| 23.1747% | |
| 17.6298% | |
| 4.7486% | |
| -10.6855% | |
| -11.0193% | |
| 12.6567% | |
| 3.3928% | |
| 12.5609% | |
| 0.9754% | |
| -50.6519% | |
| -11.4108% | |
| -52.1238% | |
| -81.0386% | |
| -45.8986% | |
| -167.2987% | |
| -87.1546% | |
| -23.6032% | |
| -32.2495% | |
| 25.4149% | |
| 38.5417% | |
| 18.7636% | |
| 27.9649% | |
| -16.114% | |
| -31.7481% | |
| -11.2809% | |
| -43.7871% | |
| 27.6358% | |
| -19.5493% | |
| -26.5846% | |
| 21.38% | |
| 13.0182% | |
| 42.5272% | |
| 40.5112% | |
| 26.1097% | |
| 45.8287% | |
| 27.8262% | |
| 27.6253% | |
| 16.9116% | |
| -260.5918% | |
| -75.1741% | |
| -69.4674% | |
| -44.0694% | |
| 16.2958% | |
| -34.4395% |